 | • レポートコード：GIR201106140 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、経口固形製剤医薬品製剤の世界市場を調査対象にし、経口固形製剤医薬品製剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（即時リリース、延長リリース、その他）、用途別分析（病院薬局、小売薬局、ドラッグストア、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AstraZeneca、AbbVie、Gilead、Bristol-Myers Squibb、Pfizer、Eli Lilly、Novartis、Merck、Boehringer Ingelheim ・メーカー別販売量、売上、市場シェア ・経口固形製剤医薬品製剤の地域別市場分析 ・経口固形製剤医薬品製剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・経口固形製剤医薬品製剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・経口固形製剤医薬品製剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・経口固形製剤医薬品製剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・経口固形製剤医薬品製剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・経口固形製剤医薬品製剤の種類別市場規模2015-2020：即時リリース、延長リリース、その他 ・経口固形製剤医薬品製剤の用途別市場規模2015-2020：病院薬局、小売薬局、ドラッグストア、その他 ・経口固形製剤医薬品製剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Oral Solid Dosage Pharmaceutical Formulation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oral Solid Dosage Pharmaceutical Formulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oral Solid Dosage Pharmaceutical Formulation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oral Solid Dosage Pharmaceutical Formulation market has been segmented into
Immediate Release
Extended Release
Others
By Application, Oral Solid Dosage Pharmaceutical Formulation has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Solid Dosage Pharmaceutical Formulation market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Solid Dosage Pharmaceutical Formulation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Solid Dosage Pharmaceutical Formulation market.
The report offers in-depth assessment of the growth and other aspects of the Oral Solid Dosage Pharmaceutical Formulation market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oral Solid Dosage Pharmaceutical Formulation Market Share Analysis
Oral Solid Dosage Pharmaceutical Formulation competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Solid Dosage Pharmaceutical Formulation sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Solid Dosage Pharmaceutical Formulation sales, revenue and market share for each player covered in this report.
The major players covered in Oral Solid Dosage Pharmaceutical Formulation are:
AstraZeneca
AbbVie
Gilead
Bristol-Myers Squibb
Pfizer
Eli Lilly
Novartis
Merck
Boehringer Ingelheim
Among other players domestic and global, Oral Solid Dosage Pharmaceutical Formulation market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Solid Dosage Pharmaceutical Formulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Solid Dosage Pharmaceutical Formulation, with price, sales, revenue and global market share of Oral Solid Dosage Pharmaceutical Formulation in 2018 and 2019.
Chapter 3, the Oral Solid Dosage Pharmaceutical Formulation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Solid Dosage Pharmaceutical Formulation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oral Solid Dosage Pharmaceutical Formulation market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oral Solid Dosage Pharmaceutical Formulation sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Oral Solid Dosage Pharmaceutical Formulation Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Immediate Release
1.2.3 Extended Release
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Drug Stores
1.3.5 Others
1.4 Overview of Global Oral Solid Dosage Pharmaceutical Formulation Market
1.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Gilead
2.3.1 Gilead Details
2.3.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Gilead SWOT Analysis
2.3.4 Gilead Product and Services
2.3.5 Gilead Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis SWOT Analysis
2.7.4 Novartis Product and Services
2.7.5 Novartis Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Solid Dosage Pharmaceutical Formulation Manufacturer Market Share in 2019
3.3.2 Top 6 Oral Solid Dosage Pharmaceutical Formulation Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Regions (2015-2020)
4.2 North America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
4.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
4.5 South America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
5.1.1 North America Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2015-2020)
5.1.2 North America Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2015-2020)
5.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
5.3 Canada Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
5.4 Mexico Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2015-2020)
6.2 Germany Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
6.3 UK Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
6.4 France Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
6.5 Russia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
6.6 Italy Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Regions (2015-2020)
7.2 China Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
7.3 Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
7.4 Korea Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
7.5 India Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
7.7 Australia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
8.1.1 South America Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2015-2020)
8.1.2 South America Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
8.3 Argentina Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
9.3 Turkey Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
9.4 Egypt Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
9.5 South Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (2015-2020)
10.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2015-2020)
10.3 Global Oral Solid Dosage Pharmaceutical Formulation Price by Type (2015-2020)
11 Global Oral Solid Dosage Pharmaceutical Formulation Market Segment by Application
11.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2015-2020)
11.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2015-2020)
11.3 Global Oral Solid Dosage Pharmaceutical Formulation Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate (2021-2025)
12.2 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Regions (2021-2025)
12.2.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025)
12.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025)
12.2.4 South America Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025)
12.3 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Type (2021-2025)
12.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2021-2025)
12.3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Type (2021-2025)
12.4 Oral Solid Dosage Pharmaceutical Formulation Market Forecast by Application (2021-2025)
12.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2021-2025)
12.4.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oral Solid Dosage Pharmaceutical Formulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oral Solid Dosage Pharmaceutical Formulation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 9. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca SWOT Analysis
Table 11. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 12. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 15. AbbVie Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 16. AbbVie SWOT Analysis
Table 17. AbbVie Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 18. AbbVie Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Gilead Basic Information, Manufacturing Base and Competitors
Table 20. Gilead Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 21. Gilead Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 22. Gilead SWOT Analysis
Table 23. Gilead Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 24. Gilead Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 26. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 27. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 28. Bristol-Myers Squibb SWOT Analysis
Table 29. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 30. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 33. Pfizer Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 34. Pfizer SWOT Analysis
Table 35. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 36. Pfizer Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 38. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 39. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 40. Eli Lilly SWOT Analysis
Table 41. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 42. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 45. Novartis Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 46. Novartis SWOT Analysis
Table 47. Novartis Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 48. Novartis Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 51. Merck Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 52. Merck SWOT Analysis
Table 53. Merck Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 54. Merck Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 56. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Major Business
Table 57. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Total Revenue (USD Million) (2018-2019)
Table 58. Boehringer Ingelheim SWOT Analysis
Table 59. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product and Services
Table 60. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Regions (2015-2020) (K Units)
Table 64. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Regions (2015-2020)
Table 65. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2015-2020) (K Units)
Table 67. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2015-2020)
Table 68. North America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2015-2020)
Table 70. Europe Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2015-2020) (K Units)
Table 71. Europe Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2015-2020)
Table 72. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2015-2020) (K Units)
Table 77. South America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2015-2020)
Table 78. South America Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2015-2020)
Table 84. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Type (2015-2020) (K Units)
Table 85. Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Type (2015-2020)
Table 86. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Type (2015-2020) (USD Million)
Table 87. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2015-2020)
Table 88. Global Oral Solid Dosage Pharmaceutical Formulation Sales by Application (2015-2020) (K Units)
Table 89. Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Application (2015-2020)
Table 90. Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Regions (2021-2025)
Table 92. Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Type (2021-2025)
Table 94. Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2021-2025)
Table 95. Global Oral Solid Dosage Pharmaceutical Formulation Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oral Solid Dosage Pharmaceutical Formulation Picture
Figure 2. Global Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type in 2019
Figure 3. Immediate Release Picture
Figure 4. Extended Release Picture
Figure 5. Others Picture
Figure 6. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application in 2018
Figure 7. Hospital Pharmacy Picture
Figure 8. Retail Pharmacy Picture
Figure 9. Drug Stores Picture
Figure 10. Others Picture
Figure 11. Global Oral Solid Dosage Pharmaceutical Formulation Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Manufacturer in 2019
Figure 32. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Oral Solid Dosage Pharmaceutical Formulation Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Oral Solid Dosage Pharmaceutical Formulation Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Regions (2015-2020)
Figure 39. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Regions in 2018
Figure 40. North America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
Figure 41. Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
Figure 43. South America Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020)
Figure 45. North America Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries (2015-2020)
Figure 47. North America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2018
Figure 48. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2018
Figure 50. United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2019
Figure 56. Germany Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Regions 2019
Figure 64. China Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2019
Figure 71. South America Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2019
Figure 72. Brazil Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
経口制御放出薬物送達技術の世界市場 2020年 Market Overview The global Oral Controlled Release Drug Delivery Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …- 注射型薬物送達製剤の世界市場 2020年 Market Overview The global Injectable Drug Delivery Formulation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Injectab…
- 虐待抑止製剤技術の世界市場 2020年 Market Overview The global Abuse Deterrent Formulation Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Abus…
- 低用量水和物阻害剤の世界市場 2020年 Market Overview The global Low dosage Hydrate Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Low dosage Hydr…
- 低用量水和物抑制剤（LDHI）の世界市場 2020年 Market Overview The global Low Dosage Hydrate Inhibitors (LDHI) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Low Dosa…